In vivo biodegradability and biocompatibility of porcine type I atelocollagen newly crosslinked by oxidized glycogen

Bio-Medical Materials and Engineering

Volumn 17, Issue 1, 2007, Pages 9-18

  Gagnieu, Christian Henry ^a   Forest, Patricia Odile ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Biodegradability biocompatibility; Collagen; Crosslinking; Oxidized glycogen

Indexed keywords

COLLAGEN MOLECULE; CROSSLINKING LEVELS; FREE ALDEHYDES; OXIDIZED GLYCOGEN;

ALDEHYDES; BIOCOMPATIBILITY; BIODEGRADABILITY; CROSSLINKING; IMPLANTS (SURGICAL); POLYSACCHARIDES;

COLLAGEN;

ALDEHYDE DERIVATIVE; ATELOCOLLAGEN; ATELOCOLLAGEN TYPE 1; COLLAGEN; GLYCOGEN; IMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CALCIFICATION; CELL ACTIVITY; CHEMICAL BOND; CHEMICAL STRUCTURE; CROSS LINKING; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; FILM; IMMUNIZATION; IMMUNOGENICITY; IMPLANT; IN VIVO STUDY; MALE; MATERIALS; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REPRODUCIBILITY; SWINE;

ABSORBABLE IMPLANTS; ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; CROSS-LINKING REAGENTS; GLYCOGEN; MALE; MICE; OXIDATION-REDUCTION; RABBITS; SWINE;

MUS; ORYCTOLAGUS CUNICULUS; SUS;

EID: 33947505313     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. K.S. Weadock, E.J. Miller, L.D. Bellincampi, J.P. Zawadsky and M.G. Dunn, Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment, J. Biomed. Mater. Res. 29(11) (1995), 1373-1379.
2. R.J. Davidson and D.R. Cooper, The effect of gamma-irradiation on soluble collagen, Biochem J. 107(1) (1968), 29-34.
3. H. Barker, R. Oliver, R. Grant and L. Stephen, Formaldehyde as a pre-treatment for dermal collagen heterografts, Biochim. Biophys. Acta 632(4) (1980), 589-597.
4. C.F. Rousseau and C.H. Gagnieu, In vitro cytocompatibility of porcine type I atelocollagen crosslinked by oxidized glycogen, Biomaterials 23(6) (2002), 1503-1510.
5. J.A. Ramshaw, J.A. Werkmeister and V. Glattauer, Collagen-based biomaterials, Biotechnol. Genet. Eng. Rev. 13(1996), 335-382.
6. M. Chvapil, L. Kronenthal andW. VanWinkle, Jr., Medical and surgical applications of collagen, Int. Rev. Connect. Tissue Res. 6(1973), 1-61.
7. S.C. Roe, B.K. Milthorpe and K. Schindhelm, Collagen cross-linking and resorption: effect of glutaraldehyde concentration, Artif. Organs 14(6) (1990), 443-448.
8. J.E. Gough, C.A. Scotchford and S. Downes, Cytotoxicity of glutaraldehyde crosslinked collagen/poly(vinyl alcohol) films is by the mechanism of apoptosis, J. Biomed. Mater. Res. 61(1) (2002), 121-130.
9. J.M. McPherson, S. Sawamura and R. Armstrong, An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants, J. Biomed. Mater. Res. 20(1) (1986), 93-107.
10. A. Cooke, R.F. Oliver and M. Edward, An in vitro cytotoxicity study of aldehyde-treated pig dermal collagen, Br. J. Exp. Pathol. 64(2) (1983), 172-176.
11. L.L. Huang-Lee, D.T. Cheung and M.E. Nimni, Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks, J. Biomed. Mater. Res. 24(9) (1990), 1185-1201.
12. G. Goissis, E. Marcantonio, Jr., R.A. Marcantonio, R.C. Lia, D.C. Cancian and W.M. de Carvalho, Biocompatibility studies of anionic collagen membranes with different degree of glutaraldehyde cross-linking, Biomaterials 20(1) (1999), 27-34.
13. G. Gong, Z. Ling, E. Seifter, S.M. Factor and R.W. Frater, Aldehyde tanning: the villain in bioprosthetic calcification, Eur. J. Cardiothorac. Surg. 5(6) (1991), 288-299; discussion 293.
14. R.J. Levy, F.J. Schoen, F.S. Sherman, J. Nichols, M.A. Hawley and S.A. Lund, Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments, Am. J. Pathol. 122(1) (1986), 71-82.
15. F.J. Schoen, J.W. Tsao and R.J. Levy, Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization, Am. J. Pathol. 123(1) (1986), 134-145.
16. D. Dormont, [Nature and physicochemical and biological properties of nonconventional transmissible agents or prions: consequences for public health], Pathol. Biol. (Paris) 43(2) (1995), 124-136.
17. D.D. Circulaire, No 100 relative aux précautions à observer en milieu chirurgical et anatomophatologique face aux risques de transmission de la maladie de Creutzfeld Jacob (11 décembre 1995).
18. Décrêt, Décrêt No 87-848 relatif aux expériences pratiquées sur les animaux. 19 octobre 1987, JO 20 octobre 1987, pp. 12245-12248.
19. Arrêtés, du 19 avril 1988 pour l'application du décret no 87-848, JO 27 avril 1987 (1988), 5607-5610.
20. Directive du Conseil Européen, Directive n 86/609/CEE du Conseil Européen concernant le rapprochement des dispositions législatives, réglementaires et administratives des Etats Membres relative à la protection des animaux utilisés à des fins expérimentales ou d'autres fins scientifiques, JOCE. No L358 du 18.12.1986 (24 novembre 1986).
21. I. Bergman and R. Loxley, The determination of hydroxyproline in urine hydrolysates, Clin. Chim. Acta 27(2) (1970), 347-349.
22. G.K. Reddy and C.S. Enwemeka, A simplified method for the analysis of hydroxyproline in biological tissues, Clin. Biochem. 29(3) (1996), 225-229.
23. A.S.G. Curtis, J.V. Forrester and P. Clark, Substrate hydroxylation and cell adhesion, J. Cell Sci. 86 (1986), 9-24.
24. J.H. Lee, J.W. Park and H.B. Lee, Cell adhesion and growth on polymer surfaces with hydroxyl groups prepared by water vapour plasma treatment, Biomaterials 12(5) (1991), 443-448.
25. D.T. Cheung, D. Tong, N. Perelman, D. Ertl and M.E. Nimni, Mechanism of crosslinking of proteins by glutaraldehyde. IV: In vitro and in vivo stability of a crosslinked collagen matrix, Connect. Tissue Res. 25(1) (1990), 27-34.
26. H. Petite, J.L. Duval, V. Frei, N. Abdul-Malak,M.F. Sigot-Luizard and D. Herbage, Cytocompatibility of calf pericardium treated by glutaraldehyde and by the acyl azide methods in an organotypic culture model, Biomaterials 16(13) (1995), 1003-1008.
27. P.B. van Wachem, J.A. Plantinga, M.J. Wissink, R. Beernink, A.A. Poot, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen and M.J. van Luyn, In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading, J. Biomed. Mater. Res. 55(3) (2001), 368-378.
28. D.T. Cheung, N. Perelman, E.C. Ko and M.E. Nimni, Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues, Connect. Tissue Res. 13(2) (1985), 109-115.
29. J.M. Ruijgrok, J.R. de Wijn and M.E. Boon, Glutaraldehyde crosslinking of collagen: effects of time, temperature, concentration and presoaking as measured by shrinkage temperature, Clin. Mater. 17(1) (1994), 23-27.
30. V. Andre-Frei, B. Chevallay, I. Orly, M. Boudeulle, A. Huc and D. Herbage, Acellular mineral deposition in collagen-based biomaterials incubated in cell culture media, Calcif. Tissue Int. 66(3) (2000), 204-211.
31. S.M. Krasovskaya, L.D. Uzhinova, M. Andrianova, A.A. Prischenko, M.V. Livantsov and M.V. Lomonosov, Biochemical and physico-chemical aspects of biomaterials calcification, Biomaterials 12(9) (1991), 817-820.
32. E. Jorge-Herrero, M.P. Gutierrez and J.L. Castillo-Olivares, Calcification of soft tissue employed in the construction of heart valve prostheses: study of different chemical treatments, Biomaterials 12(2) (1991), 249-252.
33. C.H. Lee, A. Singla and Y. Lee, Biomedical applications of collagen, Int. J. Pharm. 221(1-2) (2001), 1-22.
34. K. Meade and F. Silver, Immunogenicity of collagenous implants, Biomaterials 11(1990), 176-180.
35. C. Steffen, R. Timpl and I. Wolff, [Immunogenicity and specificity of collagen. IV. Studies of the collagen specificity of antiserums], Z. Immunitatsforsch. Allerg. Klin. Immunol. 134(3) (1967), 205-224.
36. AFNOR, ISO 10993-10 Evaluation biologique des dispositifs médicaux. Partie 10 : essais d'irritation et hypersensibilité retardée (2004).